Upgrade to SI Premium - Free Trial

Crinetics Pharmaceuticals (CRNX)

83.72 -0.18 (0.21%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Form PREM14A Crinetics Pharmaceutical For: Jul 21 July 21, 2026 4:31 PM - SEC Filing Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders July 21, 2026 7:38 AM - StreetInsider Form DEFA14A Crinetics Pharmaceutical July 10, 2026 4:03 PM - SEC Filing Form 8-K Crinetics Pharmaceutical For: Jul 06 July 10, 2026 4:02 PM - SEC Filing Stifel Downgrades Crinetics (CRNX) to Hold July 8, 2026 8:45 AM - StreetInsider Evercore ISI Downgrades Crinetics (CRNX) to In Line July 8, 2026 3:41 AM - StreetInsider Form 4 Crinetics Pharmaceutical For: Jul 02 Filed by: Vivaldi Coelho Rogerio July 7, 2026 4:31 PM - SEC Filing TD Cowen Downgrades Crinetics (CRNX) to Hold July 7, 2026 4:05 PM - StreetInsider Citizens Downgrades Crinetics (CRNX) to Market Perform July 7, 2026 12:33 PM - StreetInsider Jefferies Downgrades Crinetics (CRNX) to Hold July 7, 2026 9:58 AM - StreetInsider Jones Trading Downgrades Crinetics (CRNX) to Hold July 7, 2026 9:27 AM - StreetInsider Piper Sandler Downgrades Crinetics (CRNX) to Neutral July 7, 2026 8:27 AM - StreetInsider H.C. Wainwright Downgrades Crinetics (CRNX) to Neutral July 7, 2026 7:38 AM - StreetInsider Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced July 7, 2026 7:16 AM - StreetInsider Crinetics Pharmaceuticals (CRNX) call put ratio 13.7 calls to 1 put into Vertex Pharmaceuticals Incorporated (VRTX) acquiring July 7, 2026 5:42 AM - StreetInsider Crinetics (CRNX) PT Raised to $85 at Baird July 7, 2026 4:22 AM - StreetInsider Oppenheimer Downgrades Crinetics (CRNX) to Perform July 7, 2026 3:33 AM - StreetInsider Cantor Fitzgerald Downgrades Crinetics (CRNX) to Neutral July 7, 2026 3:30 AM - StreetInsider Form DEFA14A Crinetics Pharmaceutical July 6, 2026 5:24 PM - SEC Filing Form DEFA14A Crinetics Pharmaceutical July 6, 2026 5:18 PM - SEC Filing Form 8-K Crinetics Pharmaceutical For: Jul 06 July 6, 2026 5:17 PM - SEC Filing Crinetics soars on $10B acquisition by Vertex July 6, 2026 4:14 PM - StreetInsider Vertex to acquire Crinetics Pharmaceuticals for $10 billion July 6, 2026 4:04 PM - StreetInsider Vertex to Acquire Crinetics Pharmaceuticals July 6, 2026 4:04 PM - BizWire Form 144 Crinetics Pharmaceutical Filed by: Knight Jeff E. July 2, 2026 4:33 PM - SEC Filing Form 144 Crinetics Pharmaceutical Filed by: Vivaldi Coelho Rogerio July 2, 2026 4:29 PM - SEC Filing UBS Starts Crinetics (CRNX) at Buy July 2, 2026 4:17 AM - StreetInsider Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026 June 30, 2026 4:05 PM - StreetInsider Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: Deardorf Caren June 22, 2026 5:10 PM - SEC Filing Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: Fust Matthew K June 22, 2026 5:06 PM - SEC Filing Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: Nichols Weston June 22, 2026 5:04 PM - SEC Filing Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: Vivaldi Coelho Rogerio June 22, 2026 5:03 PM - SEC Filing Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: Bedrosian Camille L June 22, 2026 5:02 PM - SEC Filing Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: WIERENGA WENDELL June 22, 2026 5:01 PM - SEC Filing Form 4 Crinetics Pharmaceutical For: Jun 18 Filed by: Okey Stephanie June 22, 2026 5:00 PM - SEC Filing Form 8-K Crinetics Pharmaceutical For: Jun 18 June 22, 2026 4:16 PM - SEC Filing Stifel Reiterates Buy Rating on Crinetics (CRNX) June 22, 2026 9:34 AM - StreetInsider Form 4 Crinetics Pharmaceutical For: Jun 17 Filed by: Okey Stephanie June 18, 2026 5:24 PM - SEC Filing Form 144 Crinetics Pharmaceutical Filed by: Okey Stephanie June 17, 2026 4:27 PM - SEC Filing Crinetics (CRNX) Reiterated at Market Outperform by Citizens on ENDO Updates June 16, 2026 5:12 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX) June 15, 2026 6:48 AM - StreetInsider Crinetics reports two-year PALSONIFY acromegaly treatment data June 15, 2026 3:02 AM - StreetInsider Crinetics presents CAH trial data for atumelnant at ENDO 2026 June 14, 2026 4:30 PM - StreetInsider Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 June 14, 2026 4:30 PM - StreetInsider Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control June 14, 2026 2:45 PM - StreetInsider Crinetics (CRNX) Reiterated at Market Outperform by Citizens June 11, 2026 5:10 AM - StreetInsider Crinetics launches patient advocacy program for endocrine diseases June 2, 2026 4:05 PM - StreetInsider Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities June 2, 2026 4:05 PM - StreetInsider Form 4 Crinetics Pharmaceutical For: May 29 Filed by: Struthers Richard Scott June 2, 2026 4:04 PM - SEC Filing Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations June 2, 2026 4:55 AM - StreetInsider Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026 May 22, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: PRICE T ROWE ASSOCIATES INC /MD/ May 15, 2026 10:09 AM - SEC Filing Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: WELLINGTON MANAGEMENT GROUP LLP May 15, 2026 7:35 AM - SEC Filing Crinetics (CRNX) PT Lowered to $88 at Evercore ISI May 15, 2026 7:15 AM - StreetInsider Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC May 15, 2026 7:09 AM - SEC Filing Crinetics (CRNX) PT Lowered to $84 at Oppenheimer May 11, 2026 5:52 AM - StreetInsider Crinetics (CRNX) PT Lowered to $95 at Citizens After Q1 Results May 8, 2026 4:51 AM - StreetInsider Crinetics Pharmaceuticals (CRNX) Tops Q1 EPS by 5c May 7, 2026 5:28 PM - StreetInsider Form 10-Q Crinetics Pharmaceutical For: Mar 31 May 7, 2026 4:25 PM - SEC Filing Form 8-K Crinetics Pharmaceutical For: May 07 May 7, 2026 4:19 PM - SEC Filing Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update May 7, 2026 4:05 PM - StreetInsider Form 144 Crinetics Pharmaceutical Filed by: Knight Jeff E. May 4, 2026 4:27 PM - SEC Filing Form SCHEDULE 13G Crinetics Pharmaceutical Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 5:37 PM - SEC Filing Form ARS Crinetics Pharmaceutical For: Dec 31 April 29, 2026 4:21 PM - SEC Filing Form DEFA14A Crinetics Pharmaceutical April 29, 2026 4:16 PM - SEC Filing Form DEF 14A Crinetics Pharmaceutical For: Jun 18 April 29, 2026 4:15 PM - SEC Filing Crinetics (CRNX) PT Raised to $97 at Citizens on Palsonify's EU Approval April 28, 2026 4:06 AM - StreetInsider Crinetics gets European approval for acromegaly drug PALSONIFY April 27, 2026 5:15 PM - StreetInsider Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults April 27, 2026 5:13 PM - Globe NewsWire Full Article List